CVKD - CIK 0001937993
Cadrenal Therapeutics, Inc. (CVKD) reported net income of -$13.24M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$13.24M | -24.3% |
| FY 2024 | -$10.65M | -27.5% |
| FY 2023 | -$8.36M | -24.5% |
| FY 2022 | -$6.71M | - |
Cadrenal Therapeutics, Inc. (CVKD) reported net income of -$13.24M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.